Ilan Ganot - Feb 10, 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
CEO & President, Director
Signature
/s/ Erin P. Brennan as attorney-in-fact for Ilan Ganot
Stock symbol
SLDB
Transactions as of
Feb 10, 2022
Transactions value $
-$519
Form type
4
Date filed
3/8/2022, 03:39 PM
Previous filing
Jan 31, 2022
Next filing
May 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Sale -$519 -463 -15.53% $1.12 2.52K Feb 10, 2022 Wife F1
holding SLDB Common Stock 1.2M Feb 10, 2022 Direct F2
holding SLDB Common Stock 291K Feb 10, 2022 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
F2 Represents 1,141,462 shares held by Mr. Ganot as an individual, and 60,631 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship. Includes 2,272 shares acquired by Mr. Ganot under the Solid Biosciences Employee Stock Purchase Plan on September 1, 2021.
F3 Represents 290,914 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.